Izotropic Corp
Open
–
Prev. Close
–
High
–
Low
–
Market Snapshot
$21.73M
-0.04
Izotropic Corp. is engaged in the development and commercialization of IzoView, a CT imaging device with a platform of targeted uses. The company is headquartered in Surrey, British Columbia. The company went IPO on 2018-05-31. The firm is engaged in commercializing imaging-based products utilizing emerging technologies for the more accurate screening, diagnoses, and treatment of breast cancers. Its lzoView computed tomography (CT) Imaging System is intended to produce cross-sectional images of anatomy that can be imaged in the 30 cm aperture by computer reconstruction of x-ray transmission data for non-invasive visualization of tissue. The IzoView is for use in the non-invasive visualization of breast tissue, as an adjunct tool to mammography, by providing x-ray computer reconstructed images as an aid for qualified healthcare providers. The firm has not generated any revenue.
Izotropic Corp. is engaged in the development and commercialization of IzoView, a CT imaging device with a platform of targeted uses. The company is headquartered in Surrey, British Columbia. The company went IPO on 2018-05-31. The firm is engaged in commercializing imaging-based products utilizing emerging technologies for the more accurate screening, diagnoses, and treatment of breast cancers. Its lzoView computed tomography (CT) Imaging System is intended to produce cross-sectional images of anatomy that can be imaged in the 30 cm aperture by computer reconstruction of x-ray transmission data for non-invasive visualization of tissue. The IzoView is for use in the non-invasive visualization of breast tissue, as an adjunct tool to mammography, by providing x-ray computer reconstructed images as an aid for qualified healthcare providers. The firm has not generated any revenue.
Recently from Cashu
Couldn't load Cashu news
Something went wrong. Try refreshing the page.